---
title: Infographic | Going Paperless in Clinical Trials | Climedo Health
description: The EU MDR isn't the only reason for going digital with your clinical trials and Post-Market Surveillance (PMS). Other advantages include time and cost savings, improved security, better patient care and brand-new insights.
image: https://discover.climedo.com/hubfs/infographic_paperless_flatlay-EN1.png
---

![infographic_paperless_flatlay-EN1](https://discover.climedo.com/hubfs/infographic_paperless_flatlay-EN1.png "infographic_paperless_flatlay-EN1")

![logo_white_full](https://discover.climedo.com/hs-fs/hubfs/logo_white_full.png?width=3832&name=logo_white_full.png "logo_white_full")

# Going Paperless in Clinical Trials // 6 Reasons for Digitalizing Your Studies & PMS Activities in Time for the EU MDR

Since May 2021, medical devices manufacturers operating and/or selling within the EU must comply with the EU MDR (EU 2017/745). The regulation’s objective is to **improve patient safety** **by** **evaluating existing devices** (e.g. through PMS and PMCF) and **ensuring transparency** throughout a device’s lifecycle.

One major new demand of the **MDR (Annex II)** is that manufacturers’ technical documentation must be presented in a “**clear, organized, readily searchable and unambiguous manner**”. Until now, many affected companies have been working with unstructured, inflexible data collection and sharing systems, such as paper, Excel or email. Since these systems are cost-inefficient, unsafe, and likely to struggle in the post-MDR era, we can expect a surge in companies moving their technical documentation into the cloud.

But the new regulation isn't the only reason for going digital with your technical documentation. Our infographic "**Going Paperless in Clinical Trials**" offers six reasons for moving trials and post-market surveillance into the cloud. Not only will this help you become MDR compliant, it also offers benefits such as:

1. **Time Savings**
2. **Cost Savings**
3. **Increased Security**
4. **Swift Onboarding & Upskilling **
5. **Patient Support & Empowerment**
6. **Brand-New Insights**

We hope you will enjoy this Infographic! If you have any issues accessing it or any additional questions, please feel free to reach out to us at any time: 

[www.climedo.com](http://www.climedo.com)

[hello@climedo.de](mailto:hello@climedo.de)